Wockhardt Limited (WOCKPHARMA.BO)
INR 1264.45
(4.26%)
INR 1264.45
(4.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.91 Billion INR | 98.0% |
| 2022 | 4.5 Billion INR | -27.65% |
| 2021 | 6.22 Billion INR | -20.46% |
| 2020 | 7.82 Billion INR | -49.46% |
| 2019 | 15.47 Billion INR | -18.19% |
| 2018 | 18.91 Billion INR | -12.96% |
| 2017 | 21.73 Billion INR | -31.88% |
| 2016 | 31.9 Billion INR | 66.11% |
| 2015 | 19.2 Billion INR | 34.59% |
| 2014 | 14.26 Billion INR | 29.46% |
| 2013 | 11.02 Billion INR | -25.28% |
| 2012 | 14.75 Billion INR | -45.49% |
| 2011 | 27.06 Billion INR | -3.15% |
| 2010 | 27.94 Billion INR | -30.44% |
| 2009 | 40.17 Billion INR | -5.14% |
| 2008 | 42.35 Billion INR | 46.04% |
| 2007 | 28.99 Billion INR | 47.19% |
| 2006 | 19.7 Billion INR | 117.35% |
| 2005 | 9.06 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 FY | 8.91 Billion INR | 98.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 11.67 Billion INR | 0.0% |
| 2023 Q4 | 8.91 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 4.5 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 4.5 Billion INR | -27.65% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 4.88 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 8.62 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 6.22 Billion INR | -20.46% |
| 2021 Q4 | 6.22 Billion INR | 0.0% |
| 2020 Q4 | 7.82 Billion INR | 0.0% |
| 2020 FY | 7.82 Billion INR | -49.46% |
| 2020 Q2 | 13.2 Billion INR | 0.0% |
| 2019 Q2 | 18.65 Billion INR | 0.0% |
| 2019 Q4 | 15.47 Billion INR | 0.0% |
| 2019 FY | 15.47 Billion INR | -18.19% |
| 2018 Q2 | 19.61 Billion INR | 0.0% |
| 2018 Q4 | 18.91 Billion INR | 0.0% |
| 2018 FY | 18.91 Billion INR | -12.96% |
| 2017 Q4 | 21.73 Billion INR | 0.0% |
| 2017 Q2 | 28.69 Billion INR | 0.0% |
| 2017 FY | 21.73 Billion INR | -31.88% |
| 2016 Q2 | 29.61 Billion INR | 0.0% |
| 2016 FY | 31.9 Billion INR | 66.11% |
| 2016 Q4 | 31.9 Billion INR | 0.0% |
| 2015 Q2 | 13.84 Billion INR | 0.0% |
| 2015 Q4 | 19.2 Billion INR | 0.0% |
| 2015 FY | 19.2 Billion INR | 34.59% |
| 2014 FY | 14.26 Billion INR | 29.46% |
| 2014 Q2 | 8.34 Billion INR | 0.0% |
| 2014 Q4 | 14.26 Billion INR | 0.0% |
| 2013 FY | 11.02 Billion INR | -25.28% |
| 2013 Q4 | 11.02 Billion INR | 0.0% |
| 2013 Q2 | 15.24 Billion INR | 0.0% |
| 2012 Q4 | 14.75 Billion INR | 0.0% |
| 2012 FY | 14.75 Billion INR | -45.49% |
| 2011 Q4 | 27.06 Billion INR | 0.0% |
| 2011 FY | 27.06 Billion INR | -3.15% |
| 2010 FY | 27.94 Billion INR | -30.44% |
| 2009 FY | 40.17 Billion INR | -5.14% |
| 2008 FY | 42.35 Billion INR | 46.04% |
| 2007 FY | 28.99 Billion INR | 47.19% |
| 2006 FY | 19.7 Billion INR | 117.35% |
| 2005 FY | 9.06 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -1316.985% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 58.265% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -5936.176% |
| Granules India Limited | 689.71 Million INR | -1191.847% |
| Indoco Remedies Limited | 3.51 Billion INR | -153.319% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -3688.265% |
| Alkem Laboratories Limited | 400 Million INR | -2127.5% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -249829.874% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -31908.909% |
| Bajaj HealthCare Limited | 650.34 Million INR | -1270.042% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -2403.357% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -48.748% |
| Eris Lifesciences Limited | 6.54 Billion INR | -36.133% |
| FDC Limited | 2.46 Million INR | -361213.869% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -487.378% |
| Gufic Biosciences Limited | 1.53 Billion INR | -478.71% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -7882.011% |
| Ipca Laboratories Limited | 5.8 Billion INR | -53.512% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -11690.393% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -385.559% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | -3.558% |
| Lupin Limited | 1.55 Billion INR | -473.802% |
| Mankind Pharma Limited | 248.67 Million INR | -3482.961% |
| Medicamen Biotech Limited | 12.55 Million INR | -70867.742% |
| Medico Remedies Limited | 8.67 Million INR | -102644.465% |
| Megasoft Limited | 1.35 Billion INR | -556.562% |
| NATCO Pharma Limited | 53 Million INR | -16711.321% |
| Piramal Pharma Limited | 24.83 Billion INR | 64.127% |
| RPG Life Sciences Limited | -30.3 Million INR | 29505.941% |
| Sigachi Industries Limited | 265.79 Million INR | -3252.17% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -66892.481% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -4095.784% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 731026.989% |
| Unichem Laboratories Limited | 382.22 Million INR | -2231.112% |
| Wanbury Limited | 820 Million INR | -986.585% |
| Windlas Biotech Limited | 20.18 Million INR | -44052.626% |
| ZIM Laboratories Limited | 356 Million INR | -2402.767% |
| Zydus Lifesciences Limited | 251 Million INR | -3449.801% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -8258.349% |
| Divi's Laboratories Limited | 20 Million INR | -44450.0% |
| Hester Biosciences Limited | 1.81 Billion INR | -390.172% |
| Procter & Gamble Health Limited | 68.8 Million INR | -12850.581% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -63688.66% |
| Bal Pharma Limited | 363.82 Million INR | -2348.986% |
| Strides Pharma Science Limited | 6.71 Billion INR | -32.688% |
| Venus Remedies Limited | 386.8 Million INR | -2203.516% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -2227400.0% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -535.028% |
| Shilpa Medicare Limited | 5.6 Billion INR | -59.062% |
| Aarti Drugs Limited | 2.75 Billion INR | -223.612% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 11.739% |
| Valiant Laboratories Limited | 746.63 Million INR | -1093.362% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -3669.036% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -741.916% |
| Themis Medicare Limited | 267.74 Million INR | -3227.855% |
| Hikal Limited | 4.22 Billion INR | -110.713% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 44.451% |
| Sequent Scientific Limited | 1.42 Billion INR | -524.304% |
| Novartis India Limited | 50.7 Million INR | -17473.964% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 71.867% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -1883.5% |
| Morepen Laboratories Limited | 33.64 Million INR | -26386.326% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -6572.108% |